Ferric Citrate and Chronic Kidney Disease in Children

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Ferric Citrate

Auryxia® 210 mg ferric iron tablets equivalent to 1 g of FC will be supplied as 200 tablets in 400cc high-density polyethylene bottles.

DRUG

Placebo

Placebo to match Ferric Citrate tablets

Trial Locations (20)

10467

RECRUITING

Children's Hospital at Montefiore, The Bronx

11040

RECRUITING

Cohen's Childrens, New York

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

27708

NOT_YET_RECRUITING

Duke, Durham

30322

RECRUITING

Emory University, Atlanta

32806

RECRUITING

Arnold Palmer Hospital for Children, Orlando

43205

RECRUITING

Nationwide Children's, Columbus

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

46202

RECRUITING

Indiana U, Indianapolis

63130

RECRUITING

Washington U, St Louis

64110

RECRUITING

Children's Mercy Hospital, Kansas City, Kansas City

75235

RECRUITING

Children's Medical Center, Dallas, Dallas

77030

RECRUITING

Baylor College of Medicine, Houston

RECRUITING

UTH, Houston

90095

RECRUITING

University of California, Los Angeles, Los Angeles

92868

RECRUITING

Children's Hospital of Orange County, Orange

94143

RECRUITING

University of California, San Francisco, San Francisco

97239

NOT_YET_RECRUITING

OHSU, Portland

V5Z 4H4

RECRUITING

BC Children's Hospital Research Institute, Vancouver

M5G 1E8

RECRUITING

SickKids, Toronto

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Los Angeles

OTHER